13.35
0.00
(0.00%)
At close: February 25 at 1:19:14 PM CST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-43,080
-62,054
-60,079
-47,941
-14,709
Investing Cash Flow
-6,094
3,077
-16,967
-1,816
-307
Financing Cash Flow
34,702
20,881
59,475
120,676
31,611
End Cash Position
39,005
39,462
77,563
95,109
24,190
Capital Expenditure
-6,094
-10,476
-4,457
-939
-307
Issuance of Capital Stock
--
20,804
59,567
129,211
37,822
Issuance of Debt
--
500
500
--
921
Repayment of Debt
--
--
--
-10
-5,649
Free Cash Flow
-49,174
-72,530
-64,536
-48,880
-15,016
12/31/2020 - 6/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INO.MX Inovio Pharmaceuticals, Inc.
40.00
0.00%
ATOS.MX Atossa Therapeutics, Inc.
14.70
-8.13%
NRSNW NeuroSense Therapeutics Ltd.
0.2147
+7.35%
MRNA.MX Moderna, Inc.
624.80
+0.29%
ENTO Entero Therapeutics, Inc.
0.6100
+23.31%
NRSN NeuroSense Therapeutics Ltd.
1.0500
-4.11%
ITRM Iterum Therapeutics plc
1.3300
-4.66%
ATOS Atossa Therapeutics, Inc.
0.7410
-3.23%
SLS SELLAS Life Sciences Group, Inc.
1.1600
-1.69%
INO Inovio Pharmaceuticals, Inc.
1.8400
-7.07%